医学
PCSK9
重症监护医学
低密度脂蛋白胆固醇
疾病
内科学
生物信息学
胆固醇
低密度脂蛋白受体
脂蛋白
生物
作者
Mahmoud Al Rifai,Christie M. Ballantyne
标识
DOI:10.1038/s41569-021-00634-0
摘要
Human genetic studies combined with biotechnological advances have guided and accelerated the development of PCSK9-targeting therapies. In this Clinical Outlook, we highlight present and future approaches for PCSK9 inhibition to reduce LDL-cholesterol levels and the risk of atherosclerotic cardiovascular disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI